WHO's ICOPE program tested to keep seniors independent

NCT ID NCT06676839

Recruiting now Prevention Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests the WHO's ICOPE program, which includes regular check-ins on mobility, memory, nutrition, vision, hearing, and mood, plus personalized care plans. Researchers will follow 1,000 adults aged 65+ for up to 5 years to see if the program prevents age-related decline better than usual care. The goal is to help people stay independent as they age.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: WHO ICOPE program (screening, assessment, personalized care plan, and follow-up)
What this could lead to: If it works, this could provide a proven way to help older people stay independent longer by preventing declines in mobility, memory, and other key functions.
What could go wrong: This is a large but early-stage trial testing a complex program, so results may not show clear benefits or may be hard to apply broadly. The program requires significant effort from participants and healthcare providers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGEING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AGEING

Contacts and locations

Locations

Angers University hospital
RECRUITING

Angers, 49933, France
Bigorre Hospital
RECRUITING

Tarbes, France, 65000, France
CHIC
RECRUITING

Castres, France, 81108, France
CHU Toulouse
RECRUITING

Toulouse, France, 31000, France
Limoges university hospital
RECRUITING

Limoges, 87042, France
Perpignan Hospital
RECRUITING

Perpignan, France, 66046, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.